Trial record 1 of 1 for:
CL1-95012-001
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05159388 |
|
Recruitment Status :
Recruiting
First Posted : December 16, 2021
Last Update Posted : December 19, 2023
|
Sponsor:
Servier Bio-Innovation LLC
Collaborator:
Institut de Recherches Internationales Servier
Information provided by (Responsible Party):
Servier ( Servier Bio-Innovation LLC )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 31, 2027 |
| Estimated Study Completion Date : | October 31, 2027 |